This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (13)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Beth H. Lertzman, MD; Thomas McMeekin, MD; Anthony A. Gaspari, MD
Department of Dermatology University of Rochester 601 Elmwood Ave, Box 697 Rochester, NY 14642

Arch Dermatol. 1997;133(7):920-921.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Angiolymphoid hyperplasia with eosinophilia (ALHE) is an anomalous vascular proliferation that usually affects the head and neck region of young women¹ and can be a cosmetic problem. Many therapies have been used to treat ALHE with limited success, including cessation of estrogen therapy, treatment with oral retinoids and pentoxifylline, chemotherapeutics, surgical excision, electrodesiccation, and cryosurgery.^2-7 The mainstay of therapy currently includes treatment with topical, intralesional, and systemic corticosteroids.⁸ Carbon dioxide and argon lasers also have been used to treat ALHE; however, scarring has been reported.^7,9

Report of a Case.

A 30-year-old white woman presented with multiple discrete erythematous to violaceous papules and nodules, localized to her right ear and scalp (Figure 1). The patient was otherwise healthy. Her peripheral eosinophil count was slightly elevated at 1.2x10⁶/L (normal range, 0-0.648x10⁶/L). Histological study of a lesional biopsy specimen revealed an inflammatory infiltrate dominated by . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?